XML 107 R80.htm IDEA: XBRL DOCUMENT v3.21.1
FINANCIAL STATEMENTS SCHEDULE I - CONSOLIDATED STATEMENTS OF COMPANY CASH FLOW STATEMENTS (Detail)
¥ in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2020
CNY (¥)
Dec. 31, 2020
USD ($)
Dec. 31, 2019
CNY (¥)
Dec. 31, 2018
CNY (¥)
Cash flows from operating activities        
Net income ¥ 252,883 $ 38,757 ¥ 527,747 ¥ 611,758
Adjustments to reconcile net income to net cash flows from operating activities:        
Depreciation and amortization 23,158 3,549 17,710 11,300
Impairment of short-term investment 67,169 10,294    
Changes in operating assets and liabilities:        
Amount due from/to related parties 10,039 1,539 10,100 500,845
Prepaid and other current assets 26,538 4,067 (35,186) 31,242
Accrued expenses and other current liabilities (87,751) (13,448) 47,692 57,721
Net cash (used in) provided by operating activities (35,505) (5,439) 26,291 (228,368)
Cash flows from investing activities        
Purchase of short-term investment     (71,477)  
Net cash (used in) provided by investing activities 33,226 5,092 (234,178) (16,423)
Cash flows from financing activities        
Net proceeds from issuance of ordinary shares     243,629  
Proceeds from exercise of options 6,982 1,070    
Net cash (used in) provided by financing activities 10,595 1,624 244,674 (433,600)
Net increase (decrease) in cash and cash equivalents (2,829) (433) 39,208 (678,391)
Cash, cash equivalents and restricted cash at beginning of the year 122,149 18,720 82,941 761,332
Cash, cash equivalents and restricted cash at end of the year 119,320 18,287 122,149 82,941
Parent Company        
Cash flows from operating activities        
Net income 252,883 38,757 527,747 611,758
Adjustments to reconcile net income to net cash flows from operating activities:        
Share of results of subsidiaries and VIEs (319,091) (48,904) (525,722) (611,758)
Depreciation and amortization 2,675 410 2,020  
Impairment of short-term investment 67,169 10,294    
Changes in operating assets and liabilities:        
Amount due from/to related parties     (4,938)  
Amounts due from subsidiaries and VIEs (35,702) (5,471) (44,695)  
Prepaid and other current assets (2,413) (370) (3,137)  
Accrued expenses and other current liabilities (3,548) (544) 5,933  
Net cash (used in) provided by operating activities (38,027) (5,828) (42,792)  
Cash flows from investing activities        
Loan to a related party     (119,924)  
Purchase of short-term investment     (71,477)  
Cash collected from loan to related parties 37,372 5,728    
Net cash (used in) provided by investing activities 37,372 5,728 (191,401)  
Cash flows from financing activities        
Net proceeds from issuance of ordinary shares     255,928  
Proceeds from exercise of options 6,982 1,070    
Net cash (used in) provided by financing activities 6,982 1,070 255,928  
Effect of foreign exchange rate changes on cash and cash equivalents (12,337) (1,891) 5,488  
Net increase (decrease) in cash and cash equivalents (6,010) (921) 27,223  
Cash, cash equivalents and restricted cash at beginning of the year 27,223 4,172    
Cash, cash equivalents and restricted cash at end of the year ¥ 21,213 $ 3,251 ¥ 27,223  
Supplemental disclosure of significant non-cash investing and financing activities:        
Decease in investment in subsidiaries and VIEs for cash dividend paid by a subsidiary on behalf of the parent to the Company’s shareholders       ¥ (400,000)